Danish CEO hires former Novo executive to spearhead planned launch
![Julie Waras Brogren is the new commercial director at Ascelia Pharma | Foto: Ascelia Pharma / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article11806962.ece/ALTERNATES/schema-16_9/brogren.jpg)
Malmö-based company Ascelia Pharma, which is led by Danish CEO Magnus Corfitzen, is shaking up its staffing ahead of the planned launch of its contrast agent Mangoral in 2022.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.